nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—ABCB1—esophageal cancer	0.617	1	CbGaD
Mifepristone—ABCC1—Methotrexate—esophageal cancer	0.0402	0.62	CbGbCtD
Mifepristone—ABCB1—Cisplatin—esophageal cancer	0.0149	0.231	CbGbCtD
Mifepristone—ABCB1—Methotrexate—esophageal cancer	0.0097	0.15	CbGbCtD
Mifepristone—Blood potassium decreased—Capecitabine—esophageal cancer	0.00297	0.0391	CcSEcCtD
Mifepristone—Infection—Carboplatin—esophageal cancer	0.00185	0.0244	CcSEcCtD
Mifepristone—Blood triglycerides increased—Capecitabine—esophageal cancer	0.00172	0.0227	CcSEcCtD
Mifepristone—Pain—Carboplatin—esophageal cancer	0.00159	0.021	CcSEcCtD
Mifepristone—Metrorrhagia—Capecitabine—esophageal cancer	0.00158	0.0208	CcSEcCtD
Mifepristone—Vaginal haemorrhage—Capecitabine—esophageal cancer	0.00152	0.0201	CcSEcCtD
Mifepristone—Body temperature increased—Carboplatin—esophageal cancer	0.00147	0.0194	CcSEcCtD
Mifepristone—Gastrooesophageal reflux disease—Capecitabine—esophageal cancer	0.00125	0.0165	CcSEcCtD
Mifepristone—Hypokalaemia—Cisplatin—esophageal cancer	0.00101	0.0133	CcSEcCtD
Mifepristone—Breast disorder—Cisplatin—esophageal cancer	0.001	0.0132	CcSEcCtD
Mifepristone—Cramp muscle—Cisplatin—esophageal cancer	0.001	0.0132	CcSEcCtD
Mifepristone—Nasopharyngitis—Cisplatin—esophageal cancer	0.000994	0.0131	CcSEcCtD
Mifepristone—Hot flush—Capecitabine—esophageal cancer	0.000876	0.0115	CcSEcCtD
Mifepristone—Menopausal symptoms—Capecitabine—esophageal cancer	0.000868	0.0114	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Capecitabine—esophageal cancer	0.000868	0.0114	CcSEcCtD
Mifepristone—Thirst—Capecitabine—esophageal cancer	0.000861	0.0113	CcSEcCtD
Mifepristone—Pain in extremity—Capecitabine—esophageal cancer	0.000819	0.0108	CcSEcCtD
Mifepristone—Connective tissue disorder—Cisplatin—esophageal cancer	0.000755	0.00995	CcSEcCtD
Mifepristone—Hypokalaemia—Capecitabine—esophageal cancer	0.000745	0.00982	CcSEcCtD
Mifepristone—Breast disorder—Capecitabine—esophageal cancer	0.00074	0.00975	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Capecitabine—esophageal cancer	0.000738	0.00972	CcSEcCtD
Mifepristone—Nasopharyngitis—Capecitabine—esophageal cancer	0.000732	0.00965	CcSEcCtD
Mifepristone—Muscular weakness—Capecitabine—esophageal cancer	0.000722	0.00952	CcSEcCtD
Mifepristone—Mediastinal disorder—Cisplatin—esophageal cancer	0.000693	0.00913	CcSEcCtD
Mifepristone—Malnutrition—Cisplatin—esophageal cancer	0.000669	0.00882	CcSEcCtD
Mifepristone—Dermatitis exfoliative—Methotrexate—esophageal cancer	0.000646	0.00852	CcSEcCtD
Mifepristone—Muscle spasms—Cisplatin—esophageal cancer	0.000643	0.00848	CcSEcCtD
Mifepristone—Infestation NOS—Capecitabine—esophageal cancer	0.000631	0.00832	CcSEcCtD
Mifepristone—Infestation—Capecitabine—esophageal cancer	0.000631	0.00832	CcSEcCtD
Mifepristone—Ill-defined disorder—Cisplatin—esophageal cancer	0.000621	0.00818	CcSEcCtD
Mifepristone—Malaise—Cisplatin—esophageal cancer	0.000603	0.00795	CcSEcCtD
Mifepristone—Myalgia—Cisplatin—esophageal cancer	0.00057	0.00751	CcSEcCtD
Mifepristone—Haemoglobin—Capecitabine—esophageal cancer	0.00057	0.0075	CcSEcCtD
Mifepristone—Anxiety—Cisplatin—esophageal cancer	0.000568	0.00748	CcSEcCtD
Mifepristone—Haemorrhage—Capecitabine—esophageal cancer	0.000567	0.00747	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—esophageal cancer	0.000566	0.00746	CcSEcCtD
Mifepristone—Discomfort—Cisplatin—esophageal cancer	0.000563	0.00742	CcSEcCtD
Mifepristone—Oedema peripheral—Capecitabine—esophageal cancer	0.000558	0.00736	CcSEcCtD
Mifepristone—Connective tissue disorder—Capecitabine—esophageal cancer	0.000557	0.00734	CcSEcCtD
Mifepristone—Breast disorder—Methotrexate—esophageal cancer	0.000551	0.00726	CcSEcCtD
Mifepristone—Toxic epidermal necrolysis—Methotrexate—esophageal cancer	0.000549	0.00724	CcSEcCtD
Mifepristone—Oedema—Cisplatin—esophageal cancer	0.000546	0.0072	CcSEcCtD
Mifepristone—Infection—Cisplatin—esophageal cancer	0.000543	0.00715	CcSEcCtD
Mifepristone—Nervous system disorder—Cisplatin—esophageal cancer	0.000536	0.00706	CcSEcCtD
Mifepristone—Skin disorder—Cisplatin—esophageal cancer	0.00053	0.00699	CcSEcCtD
Mifepristone—Anorexia—Cisplatin—esophageal cancer	0.000521	0.00686	CcSEcCtD
Mifepristone—Angiopathy—Capecitabine—esophageal cancer	0.000514	0.00677	CcSEcCtD
Mifepristone—Mediastinal disorder—Capecitabine—esophageal cancer	0.000511	0.00673	CcSEcCtD
Mifepristone—Hypotension—Cisplatin—esophageal cancer	0.00051	0.00672	CcSEcCtD
Mifepristone—Chills—Capecitabine—esophageal cancer	0.000508	0.0067	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Cisplatin—esophageal cancer	0.000498	0.00656	CcSEcCtD
Mifepristone—Mental disorder—Capecitabine—esophageal cancer	0.000496	0.00654	CcSEcCtD
Mifepristone—Malnutrition—Capecitabine—esophageal cancer	0.000493	0.0065	CcSEcCtD
Mifepristone—PGR—epithelium—esophageal cancer	0.000487	0.0633	CbGeAlD
Mifepristone—Dyspnoea—Cisplatin—esophageal cancer	0.000487	0.00642	CcSEcCtD
Mifepristone—Back pain—Capecitabine—esophageal cancer	0.000477	0.00629	CcSEcCtD
Mifepristone—Decreased appetite—Cisplatin—esophageal cancer	0.000475	0.00626	CcSEcCtD
Mifepristone—Muscle spasms—Capecitabine—esophageal cancer	0.000474	0.00625	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000471	0.00621	CcSEcCtD
Mifepristone—Infestation—Methotrexate—esophageal cancer	0.00047	0.00619	CcSEcCtD
Mifepristone—Infestation NOS—Methotrexate—esophageal cancer	0.00047	0.00619	CcSEcCtD
Mifepristone—PGR—smooth muscle tissue—esophageal cancer	0.000469	0.061	CbGeAlD
Mifepristone—Pain—Cisplatin—esophageal cancer	0.000467	0.00615	CcSEcCtD
Mifepristone—Ill-defined disorder—Capecitabine—esophageal cancer	0.000458	0.00603	CcSEcCtD
Mifepristone—Feeling abnormal—Cisplatin—esophageal cancer	0.00045	0.00593	CcSEcCtD
Mifepristone—Malaise—Capecitabine—esophageal cancer	0.000445	0.00586	CcSEcCtD
Mifepristone—Body temperature increased—Cisplatin—esophageal cancer	0.000432	0.00569	CcSEcCtD
Mifepristone—Hypertension—Capecitabine—esophageal cancer	0.000426	0.00561	CcSEcCtD
Mifepristone—Haemoglobin—Methotrexate—esophageal cancer	0.000424	0.00559	CcSEcCtD
Mifepristone—Haemorrhage—Methotrexate—esophageal cancer	0.000422	0.00556	CcSEcCtD
Mifepristone—Myalgia—Capecitabine—esophageal cancer	0.00042	0.00553	CcSEcCtD
Mifepristone—Arthralgia—Capecitabine—esophageal cancer	0.00042	0.00553	CcSEcCtD
Mifepristone—Anxiety—Capecitabine—esophageal cancer	0.000418	0.00551	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—esophageal cancer	0.000417	0.0055	CcSEcCtD
Mifepristone—Discomfort—Capecitabine—esophageal cancer	0.000415	0.00547	CcSEcCtD
Mifepristone—NR3C1—neck—esophageal cancer	0.000413	0.0537	CbGeAlD
Mifepristone—Dry mouth—Capecitabine—esophageal cancer	0.000411	0.00541	CcSEcCtD
Mifepristone—Oedema—Capecitabine—esophageal cancer	0.000403	0.0053	CcSEcCtD
Mifepristone—Hypersensitivity—Cisplatin—esophageal cancer	0.000402	0.0053	CcSEcCtD
Mifepristone—Infection—Capecitabine—esophageal cancer	0.0004	0.00527	CcSEcCtD
Mifepristone—Nervous system disorder—Capecitabine—esophageal cancer	0.000395	0.0052	CcSEcCtD
Mifepristone—Asthenia—Cisplatin—esophageal cancer	0.000392	0.00516	CcSEcCtD
Mifepristone—Skin disorder—Capecitabine—esophageal cancer	0.000391	0.00515	CcSEcCtD
Mifepristone—AR—epithelium—esophageal cancer	0.000388	0.0504	CbGeAlD
Mifepristone—Anorexia—Capecitabine—esophageal cancer	0.000384	0.00506	CcSEcCtD
Mifepristone—Angiopathy—Methotrexate—esophageal cancer	0.000383	0.00504	CcSEcCtD
Mifepristone—AR—bronchus—esophageal cancer	0.000382	0.0497	CbGeAlD
Mifepristone—Mediastinal disorder—Methotrexate—esophageal cancer	0.00038	0.00501	CcSEcCtD
Mifepristone—Chills—Methotrexate—esophageal cancer	0.000378	0.00499	CcSEcCtD
Mifepristone—Hypotension—Capecitabine—esophageal cancer	0.000376	0.00496	CcSEcCtD
Mifepristone—AR—smooth muscle tissue—esophageal cancer	0.000374	0.0486	CbGeAlD
Mifepristone—Diarrhoea—Cisplatin—esophageal cancer	0.000374	0.00492	CcSEcCtD
Mifepristone—Mental disorder—Methotrexate—esophageal cancer	0.00037	0.00487	CcSEcCtD
Mifepristone—Malnutrition—Methotrexate—esophageal cancer	0.000367	0.00484	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Capecitabine—esophageal cancer	0.000367	0.00483	CcSEcCtD
Mifepristone—Insomnia—Capecitabine—esophageal cancer	0.000364	0.0048	CcSEcCtD
Mifepristone—ABCC1—bronchus—esophageal cancer	0.000363	0.0472	CbGeAlD
Mifepristone—Dyspnoea—Capecitabine—esophageal cancer	0.000359	0.00473	CcSEcCtD
Mifepristone—Back pain—Methotrexate—esophageal cancer	0.000355	0.00468	CcSEcCtD
Mifepristone—Decreased appetite—Capecitabine—esophageal cancer	0.00035	0.00461	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000348	0.00458	CcSEcCtD
Mifepristone—Vomiting—Cisplatin—esophageal cancer	0.000347	0.00458	CcSEcCtD
Mifepristone—Fatigue—Capecitabine—esophageal cancer	0.000347	0.00457	CcSEcCtD
Mifepristone—Rash—Cisplatin—esophageal cancer	0.000344	0.00454	CcSEcCtD
Mifepristone—Pain—Capecitabine—esophageal cancer	0.000344	0.00454	CcSEcCtD
Mifepristone—Constipation—Capecitabine—esophageal cancer	0.000344	0.00454	CcSEcCtD
Mifepristone—Dermatitis—Cisplatin—esophageal cancer	0.000344	0.00453	CcSEcCtD
Mifepristone—Ill-defined disorder—Methotrexate—esophageal cancer	0.000341	0.00449	CcSEcCtD
Mifepristone—Feeling abnormal—Capecitabine—esophageal cancer	0.000332	0.00437	CcSEcCtD
Mifepristone—Malaise—Methotrexate—esophageal cancer	0.000331	0.00436	CcSEcCtD
Mifepristone—Gastrointestinal pain—Capecitabine—esophageal cancer	0.000329	0.00434	CcSEcCtD
Mifepristone—ABCC1—trachea—esophageal cancer	0.000326	0.0423	CbGeAlD
Mifepristone—Nausea—Cisplatin—esophageal cancer	0.000324	0.00427	CcSEcCtD
Mifepristone—Urticaria—Capecitabine—esophageal cancer	0.00032	0.00421	CcSEcCtD
Mifepristone—Abdominal pain—Capecitabine—esophageal cancer	0.000318	0.00419	CcSEcCtD
Mifepristone—Body temperature increased—Capecitabine—esophageal cancer	0.000318	0.00419	CcSEcCtD
Mifepristone—Myalgia—Methotrexate—esophageal cancer	0.000313	0.00412	CcSEcCtD
Mifepristone—Arthralgia—Methotrexate—esophageal cancer	0.000313	0.00412	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—esophageal cancer	0.00031	0.00409	CcSEcCtD
Mifepristone—PGR—lung—esophageal cancer	0.000309	0.0402	CbGeAlD
Mifepristone—Discomfort—Methotrexate—esophageal cancer	0.000309	0.00407	CcSEcCtD
Mifepristone—Infection—Methotrexate—esophageal cancer	0.000298	0.00392	CcSEcCtD
Mifepristone—Hypersensitivity—Capecitabine—esophageal cancer	0.000297	0.00391	CcSEcCtD
Mifepristone—AR—digestive system—esophageal cancer	0.000295	0.0384	CbGeAlD
Mifepristone—Nervous system disorder—Methotrexate—esophageal cancer	0.000294	0.00387	CcSEcCtD
Mifepristone—Skin disorder—Methotrexate—esophageal cancer	0.000291	0.00384	CcSEcCtD
Mifepristone—Asthenia—Capecitabine—esophageal cancer	0.000289	0.00381	CcSEcCtD
Mifepristone—Anorexia—Methotrexate—esophageal cancer	0.000286	0.00376	CcSEcCtD
Mifepristone—Pruritus—Capecitabine—esophageal cancer	0.000285	0.00375	CcSEcCtD
Mifepristone—NR3C1—epithelium—esophageal cancer	0.000281	0.0365	CbGeAlD
Mifepristone—Hypotension—Methotrexate—esophageal cancer	0.00028	0.00369	CcSEcCtD
Mifepristone—NR3C1—bronchus—esophageal cancer	0.000277	0.036	CbGeAlD
Mifepristone—Diarrhoea—Capecitabine—esophageal cancer	0.000275	0.00363	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Methotrexate—esophageal cancer	0.000273	0.0036	CcSEcCtD
Mifepristone—Insomnia—Methotrexate—esophageal cancer	0.000271	0.00357	CcSEcCtD
Mifepristone—NR3C1—smooth muscle tissue—esophageal cancer	0.000271	0.0352	CbGeAlD
Mifepristone—Dyspnoea—Methotrexate—esophageal cancer	0.000267	0.00352	CcSEcCtD
Mifepristone—Somnolence—Methotrexate—esophageal cancer	0.000266	0.00351	CcSEcCtD
Mifepristone—Dizziness—Capecitabine—esophageal cancer	0.000266	0.00351	CcSEcCtD
Mifepristone—Decreased appetite—Methotrexate—esophageal cancer	0.000261	0.00343	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.000259	0.00341	CcSEcCtD
Mifepristone—Fatigue—Methotrexate—esophageal cancer	0.000258	0.0034	CcSEcCtD
Mifepristone—Pain—Methotrexate—esophageal cancer	0.000256	0.00338	CcSEcCtD
Mifepristone—Vomiting—Capecitabine—esophageal cancer	0.000256	0.00337	CcSEcCtD
Mifepristone—Rash—Capecitabine—esophageal cancer	0.000254	0.00334	CcSEcCtD
Mifepristone—Dermatitis—Capecitabine—esophageal cancer	0.000254	0.00334	CcSEcCtD
Mifepristone—Headache—Capecitabine—esophageal cancer	0.000252	0.00332	CcSEcCtD
Mifepristone—NR3C1—trachea—esophageal cancer	0.000249	0.0323	CbGeAlD
Mifepristone—Feeling abnormal—Methotrexate—esophageal cancer	0.000247	0.00325	CcSEcCtD
Mifepristone—AR—lung—esophageal cancer	0.000247	0.032	CbGeAlD
Mifepristone—Gastrointestinal pain—Methotrexate—esophageal cancer	0.000245	0.00323	CcSEcCtD
Mifepristone—Nausea—Capecitabine—esophageal cancer	0.000239	0.00315	CcSEcCtD
Mifepristone—Urticaria—Methotrexate—esophageal cancer	0.000238	0.00314	CcSEcCtD
Mifepristone—Body temperature increased—Methotrexate—esophageal cancer	0.000237	0.00312	CcSEcCtD
Mifepristone—Abdominal pain—Methotrexate—esophageal cancer	0.000237	0.00312	CcSEcCtD
Mifepristone—ABCC1—lung—esophageal cancer	0.000234	0.0304	CbGeAlD
Mifepristone—Hypersensitivity—Methotrexate—esophageal cancer	0.000221	0.00291	CcSEcCtD
Mifepristone—CYP3A5—digestive system—esophageal cancer	0.000215	0.028	CbGeAlD
Mifepristone—Asthenia—Methotrexate—esophageal cancer	0.000215	0.00283	CcSEcCtD
Mifepristone—NR3C1—digestive system—esophageal cancer	0.000214	0.0278	CbGeAlD
Mifepristone—Pruritus—Methotrexate—esophageal cancer	0.000212	0.00279	CcSEcCtD
Mifepristone—PGR—lymph node—esophageal cancer	0.000212	0.0275	CbGeAlD
Mifepristone—Diarrhoea—Methotrexate—esophageal cancer	0.000205	0.0027	CcSEcCtD
Mifepristone—Dizziness—Methotrexate—esophageal cancer	0.000198	0.00261	CcSEcCtD
Mifepristone—Vomiting—Methotrexate—esophageal cancer	0.000191	0.00251	CcSEcCtD
Mifepristone—Rash—Methotrexate—esophageal cancer	0.000189	0.00249	CcSEcCtD
Mifepristone—Dermatitis—Methotrexate—esophageal cancer	0.000189	0.00249	CcSEcCtD
Mifepristone—Headache—Methotrexate—esophageal cancer	0.000188	0.00247	CcSEcCtD
Mifepristone—CYP3A5—lung—esophageal cancer	0.00018	0.0234	CbGeAlD
Mifepristone—NR3C1—lung—esophageal cancer	0.000179	0.0232	CbGeAlD
Mifepristone—Nausea—Methotrexate—esophageal cancer	0.000178	0.00235	CcSEcCtD
Mifepristone—AR—lymph node—esophageal cancer	0.000169	0.0219	CbGeAlD
Mifepristone—CYP3A4—digestive system—esophageal cancer	0.000162	0.021	CbGeAlD
Mifepristone—ABCC1—lymph node—esophageal cancer	0.00016	0.0208	CbGeAlD
Mifepristone—CYP2D6—digestive system—esophageal cancer	0.000159	0.0207	CbGeAlD
Mifepristone—ABCB1—epithelium—esophageal cancer	0.00015	0.0196	CbGeAlD
Mifepristone—ABCB1—trachea—esophageal cancer	0.000133	0.0173	CbGeAlD
Mifepristone—NR3C1—lymph node—esophageal cancer	0.000122	0.0159	CbGeAlD
Mifepristone—ABCB1—digestive system—esophageal cancer	0.000114	0.0149	CbGeAlD
Mifepristone—ABCB1—lung—esophageal cancer	9.56e-05	0.0124	CbGeAlD
Mifepristone—ABCC1—Metabolism—CRABP1—esophageal cancer	7.97e-05	0.00034	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ALOX15—esophageal cancer	7.97e-05	0.00034	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ANXA1—esophageal cancer	7.96e-05	0.000339	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NOTCH2—esophageal cancer	7.93e-05	0.000338	CbGpPWpGaD
Mifepristone—ABCC1—Disease—B2M—esophageal cancer	7.89e-05	0.000336	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CA2—esophageal cancer	7.8e-05	0.000332	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SST—esophageal cancer	7.74e-05	0.00033	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—NOTCH1—esophageal cancer	7.73e-05	0.00033	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	7.7e-05	0.000328	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	7.62e-05	0.000325	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—TPI1—esophageal cancer	7.6e-05	0.000324	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTO1—esophageal cancer	7.6e-05	0.000324	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GNG7—esophageal cancer	7.59e-05	0.000323	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	7.58e-05	0.000323	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—BLVRB—esophageal cancer	7.57e-05	0.000323	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC52A3—esophageal cancer	7.57e-05	0.000323	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ENO1—esophageal cancer	7.56e-05	0.000322	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NOTCH3—esophageal cancer	7.54e-05	0.000321	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—GHRL—esophageal cancer	7.54e-05	0.000321	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PSME2—esophageal cancer	7.45e-05	0.000318	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PSME1—esophageal cancer	7.45e-05	0.000318	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FBXW7—esophageal cancer	7.42e-05	0.000316	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ALDOB—esophageal cancer	7.29e-05	0.000311	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PLCE1—esophageal cancer	7.25e-05	0.000309	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ADH7—esophageal cancer	7.25e-05	0.000309	CbGpPWpGaD
Mifepristone—PGR—Generic Transcription Pathway—MYC—esophageal cancer	7.2e-05	0.000307	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CALR—esophageal cancer	7.15e-05	0.000305	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—BLVRB—esophageal cancer	7.13e-05	0.000304	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC52A3—esophageal cancer	7.13e-05	0.000304	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PSME2—esophageal cancer	7.11e-05	0.000303	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—PSME1—esophageal cancer	7.11e-05	0.000303	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ALDH2—esophageal cancer	7.11e-05	0.000303	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GAPDH—esophageal cancer	7.02e-05	0.000299	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—CREBBP—esophageal cancer	7.01e-05	0.000299	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CRABP1—esophageal cancer	6.96e-05	0.000296	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FBXW7—esophageal cancer	6.92e-05	0.000295	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NOTCH2—esophageal cancer	6.77e-05	0.000288	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—GSTT1—esophageal cancer	6.76e-05	0.000288	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NOTCH3—esophageal cancer	6.71e-05	0.000286	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYP2A6—esophageal cancer	6.68e-05	0.000285	CbGpPWpGaD
Mifepristone—AR—Gene Expression—SMAD4—esophageal cancer	6.66e-05	0.000284	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	6.66e-05	0.000284	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GNG7—esophageal cancer	6.62e-05	0.000282	CbGpPWpGaD
Mifepristone—ABCB1—lymph node—esophageal cancer	6.54e-05	0.0085	CbGeAlD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	6.54e-05	0.000279	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—NOTCH1—esophageal cancer	6.44e-05	0.000275	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC10A2—esophageal cancer	6.44e-05	0.000274	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CA1—esophageal cancer	6.44e-05	0.000274	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ADH1B—esophageal cancer	6.36e-05	0.000271	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	6.35e-05	0.000271	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGS1—esophageal cancer	6.34e-05	0.00027	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ENO1—esophageal cancer	6.34e-05	0.00027	CbGpPWpGaD
Mifepristone—ABCC1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	6.33e-05	0.00027	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PSME1—esophageal cancer	6.24e-05	0.000266	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PSME2—esophageal cancer	6.24e-05	0.000266	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	6.21e-05	0.000265	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ALDH2—esophageal cancer	6.2e-05	0.000264	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TYMP—esophageal cancer	6.08e-05	0.000259	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CA1—esophageal cancer	6.07e-05	0.000258	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC10A2—esophageal cancer	6.07e-05	0.000258	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NOTCH2—esophageal cancer	6.02e-05	0.000256	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TGFBR2—esophageal cancer	6e-05	0.000256	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP26A1—esophageal cancer	5.91e-05	0.000252	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTT1—esophageal cancer	5.9e-05	0.000251	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CA2—esophageal cancer	5.89e-05	0.000251	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—CREBBP—esophageal cancer	5.84e-05	0.000249	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP2A6—esophageal cancer	5.83e-05	0.000248	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ALOX15—esophageal cancer	5.76e-05	0.000246	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SMAD4—esophageal cancer	5.68e-05	0.000242	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	5.61e-05	0.000239	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TGFBR2—esophageal cancer	5.6e-05	0.000238	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CA2—esophageal cancer	5.55e-05	0.000236	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGS1—esophageal cancer	5.53e-05	0.000235	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ENO1—esophageal cancer	5.53e-05	0.000235	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTO1—esophageal cancer	5.5e-05	0.000234	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—TPI1—esophageal cancer	5.5e-05	0.000234	CbGpPWpGaD
Mifepristone—AR—Generic Transcription Pathway—MYC—esophageal cancer	5.49e-05	0.000234	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ADH7—esophageal cancer	5.47e-05	0.000233	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PLCE1—esophageal cancer	5.47e-05	0.000233	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	5.45e-05	0.000232	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PSME1—esophageal cancer	5.44e-05	0.000232	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PSME2—esophageal cancer	5.44e-05	0.000232	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	5.43e-05	0.000231	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYP1B1—esophageal cancer	5.39e-05	0.00023	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SMAD4—esophageal cancer	5.3e-05	0.000226	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ALDOB—esophageal cancer	5.27e-05	0.000225	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	5.17e-05	0.00022	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ADH7—esophageal cancer	5.16e-05	0.00022	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PLCE1—esophageal cancer	5.16e-05	0.00022	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GAPDH—esophageal cancer	5.07e-05	0.000216	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CYP19A1—esophageal cancer	5.06e-05	0.000216	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—SMAD4—esophageal cancer	5.05e-05	0.000215	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CRABP1—esophageal cancer	5.03e-05	0.000214	CbGpPWpGaD
Mifepristone—AR—Gene Expression—NOTCH1—esophageal cancer	4.91e-05	0.000209	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ADH1B—esophageal cancer	4.8e-05	0.000204	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GNG7—esophageal cancer	4.78e-05	0.000204	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP1B1—esophageal cancer	4.7e-05	0.0002	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	4.69e-05	0.0002	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC52A3—esophageal cancer	4.66e-05	0.000199	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—BLVRB—esophageal cancer	4.66e-05	0.000199	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HIF1A—esophageal cancer	4.65e-05	0.000198	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—HMOX1—esophageal cancer	4.62e-05	0.000197	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TYMP—esophageal cancer	4.59e-05	0.000195	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	4.53e-05	0.000193	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ADH1B—esophageal cancer	4.52e-05	0.000193	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	4.5e-05	0.000192	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ALDH2—esophageal cancer	4.48e-05	0.000191	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP26A1—esophageal cancer	4.46e-05	0.00019	CbGpPWpGaD
Mifepristone—AR—Gene Expression—CREBBP—esophageal cancer	4.45e-05	0.00019	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KDR—esophageal cancer	4.45e-05	0.000189	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ABCB1—esophageal cancer	4.44e-05	0.000189	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CYP19A1—esophageal cancer	4.42e-05	0.000188	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	4.4e-05	0.000188	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ALOX15—esophageal cancer	4.35e-05	0.000185	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HIF1A—esophageal cancer	4.33e-05	0.000185	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TYMP—esophageal cancer	4.32e-05	0.000184	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTT1—esophageal cancer	4.26e-05	0.000182	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP2A6—esophageal cancer	4.21e-05	0.00018	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP26A1—esophageal cancer	4.2e-05	0.000179	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NOTCH1—esophageal cancer	4.19e-05	0.000178	CbGpPWpGaD
Mifepristone—NR3C1—Generic Transcription Pathway—MYC—esophageal cancer	4.16e-05	0.000177	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTO1—esophageal cancer	4.15e-05	0.000177	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—TPI1—esophageal cancer	4.15e-05	0.000177	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ALOX15—esophageal cancer	4.1e-05	0.000175	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—HMOX1—esophageal cancer	4.03e-05	0.000172	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGS1—esophageal cancer	3.99e-05	0.00017	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ENO1—esophageal cancer	3.99e-05	0.00017	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ALDOB—esophageal cancer	3.98e-05	0.000169	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC10A2—esophageal cancer	3.97e-05	0.000169	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CA1—esophageal cancer	3.97e-05	0.000169	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOS2—esophageal cancer	3.94e-05	0.000168	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PSME1—esophageal cancer	3.94e-05	0.000168	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PSME2—esophageal cancer	3.94e-05	0.000168	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTO1—esophageal cancer	3.91e-05	0.000167	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TPI1—esophageal cancer	3.91e-05	0.000167	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOTCH1—esophageal cancer	3.9e-05	0.000166	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ABCB1—esophageal cancer	3.87e-05	0.000165	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GAPDH—esophageal cancer	3.83e-05	0.000163	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	3.82e-05	0.000163	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CREBBP—esophageal cancer	3.8e-05	0.000162	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CRABP1—esophageal cancer	3.79e-05	0.000162	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ALDOB—esophageal cancer	3.75e-05	0.00016	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NOTCH1—esophageal cancer	3.72e-05	0.000159	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	3.7e-05	0.000157	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CA2—esophageal cancer	3.63e-05	0.000155	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GNG7—esophageal cancer	3.61e-05	0.000154	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GAPDH—esophageal cancer	3.61e-05	0.000154	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CRABP1—esophageal cancer	3.58e-05	0.000152	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CREBBP—esophageal cancer	3.54e-05	0.000151	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MYC—esophageal cancer	3.47e-05	0.000148	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GNG7—esophageal cancer	3.4e-05	0.000145	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NOS3—esophageal cancer	3.4e-05	0.000145	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP1B1—esophageal cancer	3.4e-05	0.000145	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ALDH2—esophageal cancer	3.38e-05	0.000144	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—CREBBP—esophageal cancer	3.38e-05	0.000144	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PLCE1—esophageal cancer	3.37e-05	0.000144	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ADH7—esophageal cancer	3.37e-05	0.000144	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	3.35e-05	0.000143	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTT1—esophageal cancer	3.22e-05	0.000137	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYP19A1—esophageal cancer	3.19e-05	0.000136	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ALDH2—esophageal cancer	3.19e-05	0.000136	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—ERBB2—esophageal cancer	3.18e-05	0.000136	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP2A6—esophageal cancer	3.18e-05	0.000135	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOS3—esophageal cancer	3.17e-05	0.000135	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTT1—esophageal cancer	3.03e-05	0.000129	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGS1—esophageal cancer	3.01e-05	0.000128	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ENO1—esophageal cancer	3.01e-05	0.000128	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.01e-05	0.000128	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP2A6—esophageal cancer	3e-05	0.000128	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PSME2—esophageal cancer	2.97e-05	0.000127	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PSME1—esophageal cancer	2.97e-05	0.000127	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CREBBP—esophageal cancer	2.96e-05	0.000126	CbGpPWpGaD
Mifepristone—ABCC1—Disease—ERBB2—esophageal cancer	2.96e-05	0.000126	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ADH1B—esophageal cancer	2.96e-05	0.000126	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—HMOX1—esophageal cancer	2.91e-05	0.000124	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTGS2—esophageal cancer	2.9e-05	0.000124	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGS1—esophageal cancer	2.84e-05	0.000121	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ENO1—esophageal cancer	2.84e-05	0.000121	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TYMP—esophageal cancer	2.83e-05	0.00012	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCND1—esophageal cancer	2.81e-05	0.00012	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PSME1—esophageal cancer	2.8e-05	0.000119	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PSME2—esophageal cancer	2.8e-05	0.000119	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ABCB1—esophageal cancer	2.8e-05	0.000119	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP26A1—esophageal cancer	2.75e-05	0.000117	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN1A—esophageal cancer	2.72e-05	0.000116	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALOX15—esophageal cancer	2.68e-05	0.000114	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—NOS3—esophageal cancer	2.65e-05	0.000113	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MYC—esophageal cancer	2.64e-05	0.000113	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EP300—esophageal cancer	2.59e-05	0.00011	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CREBBP—esophageal cancer	2.59e-05	0.00011	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP1B1—esophageal cancer	2.56e-05	0.000109	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TPI1—esophageal cancer	2.56e-05	0.000109	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTO1—esophageal cancer	2.56e-05	0.000109	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN1A—esophageal cancer	2.53e-05	0.000108	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALDOB—esophageal cancer	2.45e-05	0.000104	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTGS2—esophageal cancer	2.43e-05	0.000103	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP1B1—esophageal cancer	2.41e-05	0.000103	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EP300—esophageal cancer	2.41e-05	0.000103	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYP19A1—esophageal cancer	2.41e-05	0.000103	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GAPDH—esophageal cancer	2.36e-05	0.0001	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CRABP1—esophageal cancer	2.34e-05	9.96e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—NOS3—esophageal cancer	2.32e-05	9.86e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYP19A1—esophageal cancer	2.27e-05	9.67e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MYC—esophageal cancer	2.25e-05	9.6e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GNG7—esophageal cancer	2.22e-05	9.47e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EGFR—esophageal cancer	2.2e-05	9.39e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—HMOX1—esophageal cancer	2.2e-05	9.37e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTGS2—esophageal cancer	2.12e-05	9.02e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MYC—esophageal cancer	2.1e-05	8.95e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALDH2—esophageal cancer	2.08e-05	8.88e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—HMOX1—esophageal cancer	2.07e-05	8.83e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EGFR—esophageal cancer	2.05e-05	8.76e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—EP300—esophageal cancer	2.02e-05	8.6e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MYC—esophageal cancer	2e-05	8.54e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ABCB1—esophageal cancer	1.99e-05	8.47e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTT1—esophageal cancer	1.98e-05	8.44e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP2A6—esophageal cancer	1.96e-05	8.35e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CA—esophageal cancer	1.91e-05	8.15e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CREBBP—esophageal cancer	1.87e-05	7.96e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGS1—esophageal cancer	1.86e-05	7.91e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ENO1—esophageal cancer	1.86e-05	7.91e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—esophageal cancer	1.85e-05	7.89e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PSME2—esophageal cancer	1.83e-05	7.8e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PSME1—esophageal cancer	1.83e-05	7.8e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CA—esophageal cancer	1.78e-05	7.6e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—EP300—esophageal cancer	1.76e-05	7.5e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NOS3—esophageal cancer	1.67e-05	7.13e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP1B1—esophageal cancer	1.58e-05	6.73e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTGS2—esophageal cancer	1.53e-05	6.52e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CA—esophageal cancer	1.49e-05	6.36e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYP19A1—esophageal cancer	1.48e-05	6.33e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CREBBP—esophageal cancer	1.41e-05	6.01e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HMOX1—esophageal cancer	1.35e-05	5.77e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CREBBP—esophageal cancer	1.33e-05	5.66e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CA—esophageal cancer	1.3e-05	5.55e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCB1—esophageal cancer	1.3e-05	5.54e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—EP300—esophageal cancer	1.27e-05	5.42e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NOS3—esophageal cancer	1.26e-05	5.38e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NOS3—esophageal cancer	1.19e-05	5.07e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTGS2—esophageal cancer	1.15e-05	4.92e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTGS2—esophageal cancer	1.09e-05	4.64e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—EP300—esophageal cancer	9.61e-06	4.09e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CA—esophageal cancer	9.42e-06	4.01e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—EP300—esophageal cancer	9.05e-06	3.86e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CREBBP—esophageal cancer	8.69e-06	3.7e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NOS3—esophageal cancer	7.78e-06	3.32e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTGS2—esophageal cancer	7.12e-06	3.03e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CA—esophageal cancer	7.11e-06	3.03e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CA—esophageal cancer	6.7e-06	2.85e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—EP300—esophageal cancer	5.92e-06	2.52e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CA—esophageal cancer	4.38e-06	1.87e-05	CbGpPWpGaD
